PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.82%
Net income growth 1.25-1.5x MRVL's 16.19%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
3.51%
D&A growth well above MRVL's 1.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
180.05%
Some yoy growth while MRVL is negative at -257.14%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-3.00%
Negative yoy SBC while MRVL is 22.61%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-828.21%
Both reduce yoy usage, with MRVL at -32.93%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-165.64%
Both yoy AR lines negative, with MRVL at -50.89%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-116.35%
Both reduce yoy inventory, with MRVL at -218.89%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
131.35%
AP growth well above MRVL's 89.84%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
61.98%
Lower 'other working capital' growth vs. MRVL's 256.27%. David Dodd would see fewer unexpected short-term demands on cash.
34.51%
Some yoy increase while MRVL is negative at -28.02%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-45.08%
Negative yoy CFO while MRVL is 3.15%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-29.42%
Negative yoy CapEx while MRVL is 20.08%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
27.25%
Purchases well above MRVL's 46.35%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
214.86%
We have some liquidation growth while MRVL is negative at -51.48%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
55052.00%
We have some outflow growth while MRVL is negative at -118.30%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
408.43%
We have mild expansions while MRVL is negative at -5349.55%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-2.95%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-650.00%
We cut yoy buybacks while MRVL is 59.34%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.